000			01125 a2200325 4500
005			20250515210401.0
264		0	_c20101028
008			201010s 0 0 fre d
022			_a2214-8116
024	7		_a10.1016/j.jmv.2010.01.077 _2doi
040			_aNLM _beng _cNLM
100	1		_aGodier, A
245	0	0	_a[A new deal with new anticoagulants?]. _h[electronic resource]
260			_bJournal des maladies vasculaires _cJun 2010
300			_a146-54 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aAntithrombins _xtherapeutic use
650	0	4	_aFactor Xa Inhibitors
650	0	4	_aFondaparinux
650	0	4	_aHumans
650	0	4	_aMorpholines _xtherapeutic use
650	0	4	_aOligosaccharides _xtherapeutic use
650	0	4	_aPolysaccharides _xtherapeutic use
650	0	4	_aRivaroxaban
650	0	4	_aThiophenes _xtherapeutic use
700	1		_aSamama, C-M
773	0		_tJournal des maladies vasculaires _gvol. 35 _gno. 3 _gp. 146-54
856	4	0	_uhttps://doi.org/10.1016/j.jmv.2010.01.077 _zAvailable from publisher's website
999			_c19545541 _d19545541